Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

Turnstone Biologics (TSBX)

Turnstone Biologics Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TSBX
DateTimeSourceHeadlineSymbolCompany
12/11/202421:20Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TSBXTurnstone Biologics Corporation
12/11/202421:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TSBXTurnstone Biologics Corporation
12/11/202421:05GlobeNewswire Inc.Turnstone Biologics Corp. Reports Third Quarter 2024 Financial Results and Provides Recent Business HighlightsNASDAQ:TSBXTurnstone Biologics Corporation
05/11/202414:01GlobeNewswire Inc.Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2024 Society for Immunotherapy of Cancer (SITC) Annual MeetingNASDAQ:TSBXTurnstone Biologics Corporation
11/10/202410:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TSBXTurnstone Biologics Corporation
11/10/202410:00GlobeNewswire Inc.Turnstone Biologics Announces Strategic Restructuring to Prioritize Portfolio and Extend Financial RunwayNASDAQ:TSBXTurnstone Biologics Corporation
01/10/202420:40Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TSBXTurnstone Biologics Corporation
14/08/202420:23Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TSBXTurnstone Biologics Corporation
14/08/202420:18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TSBXTurnstone Biologics Corporation
14/08/202420:05GlobeNewswire Inc.Turnstone Biologics Corp. Reports Second Quarter 2024 Financial Results and Provides Recent Business HighlightsNASDAQ:TSBXTurnstone Biologics Corporation
14/08/202420:01GlobeNewswire Inc.Turnstone Biologics Corp. Reports Positive Initial Data from Phase 1 Trial of TIDAL-01 in Metastatic Colorectal CancerNASDAQ:TSBXTurnstone Biologics Corporation
05/06/202421:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TSBXTurnstone Biologics Corporation
31/05/202420:23Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:TSBXTurnstone Biologics Corporation
13/05/202421:15Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TSBXTurnstone Biologics Corporation
13/05/202421:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TSBXTurnstone Biologics Corporation
13/05/202421:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TSBXTurnstone Biologics Corporation
13/05/202421:01GlobeNewswire Inc.Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business HighlightsNASDAQ:TSBXTurnstone Biologics Corporation
08/05/202413:00GlobeNewswire Inc.Turnstone Biologics to Present at the 2024 Bank of America Securities Health Care ConferenceNASDAQ:TSBXTurnstone Biologics Corporation
16/04/202413:00GlobeNewswire Inc.Turnstone Biologics Appoints William Waddill to its Board of DirectorsNASDAQ:TSBXTurnstone Biologics Corporation
21/03/202421:06GlobeNewswire Inc.Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Recent Business HighlightsNASDAQ:TSBXTurnstone Biologics Corporation
05/03/202413:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TSBXTurnstone Biologics Corporation
21/02/202411:00GlobeNewswire Inc.Turnstone Biologics to Participate in Upcoming Investor ConferencesNASDAQ:TSBXTurnstone Biologics Corporation
20/02/202422:00GlobeNewswire Inc.Turnstone Biologics Announces the Passing of Chief Legal Officer P. Joseph Campisi, Jr., Esq.NASDAQ:TSBXTurnstone Biologics Corporation
27/11/202311:00GlobeNewswire Inc.Turnstone Biologics to Participate in the Piper Sandler 35th Annual Healthcare ConferenceNASDAQ:TSBXTurnstone Biologics Corporation
10/11/202302:49GlobeNewswire Inc.Turnstone Biologics Corp. Reports Third Quarter 2023 Financial Results and Provides Recent Business HighlightsNASDAQ:TSBXTurnstone Biologics Corporation
03/11/202310:00GlobeNewswire Inc.Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2023 Society for Immunotherapy of Cancer (SITC) Annual MeetingNASDAQ:TSBXTurnstone Biologics Corporation
30/10/202310:00GlobeNewswire Inc.Turnstone Biologics Expands Scientific Advisory Board with Appointment of Dr. Jeffrey S. WeberNASDAQ:TSBXTurnstone Biologics Corporation
17/10/202322:42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TSBXTurnstone Biologics Corporation
17/10/202322:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TSBXTurnstone Biologics Corporation
17/10/202322:38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TSBXTurnstone Biologics Corporation
 Showing the most relevant articles for your search:NASDAQ:TSBX